☆ 4.8 Expression of Concern

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (Expression of Concern of 10.1016/S0140-6736(20)31180-6, 2020)

LANCET (2020)

Journal

LANCET

Volume 395, Issue 10240, Pages E102-E102

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/S0140-6736(20)31290-3

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

Anonymous

Reviews

Primary Rating

4.8

Not enough ratings

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (Expression of Concern of 10.1016/S0140-6736(20)31180-6, 2020)

Journal

LANCET

Publisher

ELSEVIER SCIENCE INC

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (Expression of Concern of 10.1016/S0140-6736(20)31180-6, 2020)

Journal

LANCET

Publisher

ELSEVIER SCIENCE INC

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper